BIO-key International
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of BIO-key International generated cash of -$3,793,456, which is more than the previous year. Cash used in financing activities reached the amount of $1,433,440 last year. Net change in cash is therefore -$2,124,123.
Cash Flow
| 2014 | -2.50M | -18.63K | 1.34M |
|---|---|---|---|
| 2015 | -15.56M | -3.36K | 19.04M |
| 2016 | -4.44M | -52.97K | 1.24M |
| 2017 | -2.46M | -226.75K | 1.91M |
| 2018 | -1.61M | -82.45K | 1.73M |
| 2019 | -1.85M | -543.31K | 2.14M |
| 2020 | -4.95M | -2.22M | 24.09M |
| 2021 | -8.97M | -42.02K | -218.59K |
| 2022 | -6.22M | -696.61K | 1.90M |
| 2023 | -3.79M | -1K | 1.43M |
BKYI Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 2.63M | 7.75M | 16.99M | 79.01K | 323.94K | 288.72K | 1.06M | 4.32M | 843.63K | 2.02M |
Operating activities | ||||||||||
Net income | -8.52M | -11.90M | -5.06M | -9.67M | -14.58M | -6.86M | -4.27M | -4.18M | -1.85M | -1.88M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 590.14K | 546.01K | 514.07K | 426.90K | 1.00M | 1.61M | 1.57M | 62.64K | 56.60K | 68.80K |
Stock-based compensation expense | 265.73K | 387.90K | 314.71K | 792.09K | 947.72K | 0 | 940.73K | 427.84K | 324.11K | 207.25K |
| Deferred income tax benefit | 265.73K | 387.90K | 314.71K | 792.09K | 947.72K | 0 | 940.73K | 427.84K | 324.11K | 207.25K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -478.56K | -339.38K | -672.57K | -237.25K | 883.67K | 1.34M | -1.00M | 258.15K | -2.72M | -341.31K |
Inventories | 402.12K | 106.29K | -4.60M | 98.17K | 569.71K | -51.98K | -481.41K | -116.78K | -336.82K | -2.44K |
Accounts payable | 57.72K | 239.14K | 183.61K | -600.39K | 438.02K | -17.96K | 32.38K | -691.71K | 811.24K | -193.60K |
Cash generated by operating activities | -3.79M | -6.22M | -8.97M | -4.95M | -1.85M | -1.61M | -2.46M | -4.44M | -15.56M | -2.50M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 614.57M | 0 | -512.82K | -512.82K | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -1K | -82.04K | -42.02K | -35.56K | -30.48K | -82.45K | -226.75K | -52.97K | -3.36K | -18.63K |
Acquisitions Net | 0 | -623.57K | 0 | -1.89M | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -1K | -696.61K | -42.02K | -2.22M | -543.31K | -82.45K | -226.75K | -52.97K | -3.36K | -18.63K |
Financing activities | ||||||||||
Common Stock Issued | 3.75M | 56.38K | 36.63K | 22.17M | -361.27K | 1.87M | 2M | 1.86M | 19.5T | 1.59M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | -630.40K | -535.1K | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -2.31M | 2.00M | -250K | -4.94M | 2.51M | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 1.43M | 1.90M | -218.59K | 24.09M | 2.14M | 1.73M | 1.91M | 1.24M | 19.04M | 1.34M |
Net Change In Cash | -2.12M | -5.11M | -9.23M | 16.91M | -244.93K | 35.22K | -772.58K | -3.25M | 3.47M | -1.17M |
Cash at end of period | 511.39K | 2.63M | 7.75M | 16.99M | 79.01K | 323.94K | 288.72K | 1.06M | 4.32M | 843.63K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |